Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in <i>DICER1</i>

Abstract

This work provides the first quantitative analysis of site-specific neoplasm risk and excess malignancy risk in 102 systematically characterized nonproband DICER1 carriers. Our findings inform DICER1 syndrome phenotype, natural history, and genetic counseling.